Other studies have shown that the low CBX7 expression was an independent predictor for poor prognosis in colon cancers, and the CBX7 negatively regulates KRAS through miR-155 to inhibit the anti-apoptotic activity, suggesting that CBX7 may play a role as an antioncogene [6,16]. Here, KRAS is linked to malignant colon neoplasm.